← Map/THREAD · HLA-B27-GENETICS
HLA-B27 Genetics
The gene most strongly linked to AS, and what flips it from a risk factor into active disease.
Why this is a thread
HLA-B27 is the gene most strongly linked to AS, most people with AS carry it. But carrying the gene doesn't mean you'll develop the disease. Only a fraction of people who are HLA-B27 positive ever get AS, which means whatever tips the scale from 'risk' to 'active disease' is doing some of the most important work in the AS story. Recent research in this thread connects HLA-B27 to specific gut bacteria and to changes in how the body handles certain amino acids. The conversation between genes and the gut may be where the answer lives.
8 papers on the board
HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation
Gut Microbes
Shows that HLA-B27, the gene most strongly linked to AS, reshapes which bacteria live in the gut and how the body handles certain amino acids, which in turn activates the inflammatory immune cells driving the disease. Suggests targeting the gut and these metabolic changes could become a real treatment route.
Difficult-to- manage and treatment refractory axial Spondyloarthritis: Systematic review and meta-analysis of prevalence and determinants.
Autoimmunity reviews
Pooling 11 studies of 5,648 patients, about one in ten people with axial spondyloarthritis have difficult-to-manage disease despite two or more biologics, and the strongest links were fibromyalgia, smoking and carrying HLA-B27. Persistent symptoms often reflect something other than ongoing inflammation, which changes what the next step should be.
Two patterns of sacroiliac joint bone marrow oedema are apparent in AxSpA determined by HLA-B27 status, body mass index or psoriasis.
Joint bone spine
MRI scans of 203 people with axial spondyloarthritis showed two different patterns of inflammation in the sacroiliac joints: a lower pattern tied to HLA-B27, male sex and X-ray damage, and an upper pattern tied to higher body weight, psoriasis and older age, which responded well to biologics. The disease may follow somewhat different paths depending on genetics versus mechanical load, and the scan can show which.
Ten millennia of purifying selection on HLA-B27 reveals an ancient epidemic-scale burden of spondyloarthritis in West Eurasia.
Autoimmunity reviews
Ancient DNA from nearly 16,000 people shows HLA-B27 was carried by about half of West Eurasians 8,500 years ago and has been steadily selected against ever since, down to about 4 percent today. The gene likely protected against infections in the past, and the disease it predisposes to was once common enough to shape human genetics.
Why Do Some Therapies Work While Others Fail? Mechanisms of Response and Emerging Treatments in axial Spondyloarthritis: 2026 SPARTAN Annual Meeting Proceedings.
Current rheumatology reports
This 2026 review explains why some drugs work in axial spondyloarthritis and others do not: HLA-B27 can present fragments that expand a specific population of T cells making TNF and IL-17, while IL-23 matters less once inflammation is established, which fits the failure of IL-23 blockers. It names the next targets, including an interferon signature seen in people who fail TNF and IL-17 drugs and a macrophage factor called MIF.
Lower HLA-B27 positivity and heterogeneous late-onset case proportions across axial spondyloarthritis cohorts: a systematic review and meta-analysis.
Rheumatology international
Pooling 42 studies, about one in eight people with axial spondyloarthritis first had symptoms after age 45, and those late starters were half as likely to carry the HLA-B27 gene. If you were diagnosed later in life and tested HLA-B27 negative, that is a recognised pattern, not an oddity.
Refinement of the Pathogenic T Cell Receptor Motif Suggests Type 17 CD8+ T Cells Initiate HLA-B*27-associated Autoimmunity.
bioRxiv : the preprint server for biology
A specific family of killer T cells that recognise HLA-B27 was found in people with axial spondyloarthritis, uveitis and psoriatic arthritis but not healthy controls, and these cells appear to switch into an IL-17-producing mode in the gut. It is a direct line from the HLA-B27 gene, through the gut, to the inflammation that IL-17 drugs block, in one set of cells.
Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.
Frontiers in immunology
This review maps every kind of marker used to diagnose axial spondyloarthritis, from HLA-B27 and CRP through genomics and metabolomics to MRI read by deep-learning models, and how combining them is starting to shorten the typical two-to-six-year wait for a diagnosis. For anyone who waited years, it explains why, and what is changing.